These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 1419777)
1. Lactic dehydrogenase virus infection prevents development of anti-nuclear antibody in (NZB x NZW)F1 mice; role of prostaglandin E2 and macrophage Ia antigen expression. Hayashi T; Mori I; Yamamoto H Int J Exp Pathol; 1992 Oct; 73(5):593-601. PubMed ID: 1419777 [TBL] [Abstract][Full Text] [Related]
2. Suppression of development of anti-nuclear antibody and glomerulonephritis in NZB x NZWF1 mice by persistent infection with lactic dehydrogenase virus: possible involvement of superoxide anion as a progressive effector. Hayashi T; Noguchi Y; Kameyama Y Int J Exp Pathol; 1993 Dec; 74(6):553-60. PubMed ID: 8292553 [TBL] [Abstract][Full Text] [Related]
3. Effect of prostaglandin E2 on plasma lactic dehydrogenase activity in (NZB x NZW)F1 mice with a chronic infection of lactic dehydrogenase virus. Hayashi T J Comp Pathol; 1992 Jul; 107(1):41-8. PubMed ID: 1430347 [TBL] [Abstract][Full Text] [Related]
4. Immune responses in mice infected with lactic dehydrogenase virus. IV. Functional status of the macrophage during acute LDV infection. Michaelides MC; Simms ES Immunology; 1979 Feb; 36(2):241-6. PubMed ID: 86506 [TBL] [Abstract][Full Text] [Related]
5. Lactic dehydrogenase virus (LDV) impairs the antigen-presenting capacity of macrophages yet fails to affect their phagocytic activity. Isakov N; Feldman M; Segal S Immunobiology; 1982; 162(1):15-27. PubMed ID: 7106838 [TBL] [Abstract][Full Text] [Related]
6. Ia antigens and Fc receptors of mouse peritoneal macrophages as determinants of susceptibility to lactic dehydrogenase virus. Inada T; Mims CA J Gen Virol; 1985 Jul; 66 ( Pt 7)():1469-77. PubMed ID: 3860626 [TBL] [Abstract][Full Text] [Related]
7. A tumor-associated lactic dehydrogenase virus suppresses the host resistance to infection with Listeria monocytogenes. Isakov N; Segal S Immunobiology; 1983 May; 164(5):402-16. PubMed ID: 6873999 [TBL] [Abstract][Full Text] [Related]
8. Suppression of development of diabetes in NOD mice by lactate dehydrogenase virus infection. Takei I; Asaba Y; Kasatani T; Maruyama T; Watanabe K; Yanagawa T; Saruta T; Ishii T J Autoimmun; 1992 Dec; 5(6):665-73. PubMed ID: 1489482 [TBL] [Abstract][Full Text] [Related]
9. Neonatal infection of mice with lactate dehydrogenase-elevating virus results in suppression of humoral antiviral immune response but does not alter the course of viraemia or the polyclonal activation of B cells and immune complex formation. Rowland RR; Even C; Anderson GW; Chen Z; Hu B; Plagemann PG J Gen Virol; 1994 May; 75 ( Pt 5)():1071-81. PubMed ID: 8176369 [TBL] [Abstract][Full Text] [Related]
10. Transplacental lactate dehydrogenase-elevating virus (LDV) transmission: immune inhibition of umbilical cord infection, and correlation of fetal virus susceptibility with development of F4/80 antigen expression. Zitterkopf NL; Haven TR; Huela M; Bradley DS; Cafruny WA Placenta; 2002 May; 23(5):438-46. PubMed ID: 12061860 [TBL] [Abstract][Full Text] [Related]
11. Immune responses in mice infected with lactic dehydrogenase virus. I. Antibody response to DNP-BGG and hyperglobulinaemia in BALB/c mice. Michaelides MC; Simms ES Immunology; 1977 Jun; 32(6):981-8. PubMed ID: 885591 [TBL] [Abstract][Full Text] [Related]
12. Suppression of development of glomerulonephritis in NZB x NZWF1 mice by persistent infection with lactic dehydrogenase virus: relations between intercellular adhesion molecule-1 expression on endothelial cells and leucocyte accumulation in glomeruli. Kameyama Y; Hayashi T Int J Exp Pathol; 1994 Aug; 75(4):295-304. PubMed ID: 7947231 [TBL] [Abstract][Full Text] [Related]
13. Pattern of infection and selective loss of Ia positive cells in suckling and adult mice inoculated with lactic dehydrogenase virus. Inada T; Mims CA Arch Virol; 1985; 86(3-4):151-65. PubMed ID: 3864399 [TBL] [Abstract][Full Text] [Related]
15. Enhanced clearance of lactic dehydrogenase-5 in severe combined immunodeficiency (SCID) mice: effect of lactic dehydrogenase virus on enzyme clearance. Hayashi T; Ozaki M; Mori I; Saito M; Itoh T; Yamamoto H Int J Exp Pathol; 1992 Apr; 73(2):173-81. PubMed ID: 1571277 [TBL] [Abstract][Full Text] [Related]
16. The IA antigen is not the major receptor for lactate dehydrogenase-elevating virus on macrophages from CBA and BALB/c mice. Buxton IK; Chan SP; Plagemann PG Virus Res; 1988 Feb; 9(2-3):205-19. PubMed ID: 3162628 [TBL] [Abstract][Full Text] [Related]
17. Nitric oxide production by splenic macrophages is not responsible for T cell suppression during acute infection with lactate dehydrogenase-elevating virus. Rowland RR; Butz EA; Plagemann PG J Immunol; 1994 Jun; 152(12):5785-95. PubMed ID: 8207208 [TBL] [Abstract][Full Text] [Related]
18. Replication of lactate dehydrogenase-elevating virus in C58 mice and quantification of antiviral antibodies and of tissue virus levels as a function of development of paralytic disease. Cafruny WA; Strancke CR; Kowalchyk K; Plagemann PG J Gen Virol; 1986 Jan; 67 ( Pt 1)():27-37. PubMed ID: 3944584 [TBL] [Abstract][Full Text] [Related]
19. Blocking of cell-mediated immunity to Moloney murine sarcoma virus-transformed cells by lactate dehydrogenase virus-antibody complex. McDonald TL J Natl Cancer Inst; 1983 Mar; 70(3):493-7. PubMed ID: 6572738 [TBL] [Abstract][Full Text] [Related]
20. Mouse Ia antigens are receptors for lactate dehydrogenase virus. Inada T; Mims CA Nature; 1984 May 3-9; 309(5963):59-61. PubMed ID: 6585645 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]